Prism Geo · city intelligence · pilot
Prism Geo · United States · Minnesota · Minneapolis · What research is done in Minneapolis?
Research · Minneapolis

What research is done in Minneapolis?

Papers authored at Minneapolis's institutions — University of Minnesota, University of Minnesota System, University of Minnesota Medical Center — with the Prism stance layer.

Summary

Research is deep and strongly university-led. Local institutions produced 13015 papers in the visible record, with the University of Minnesota responsible for 9818. Children's health, women's health, machine learning, mental health and neuroscience stand out, though health topics also attract caution.

WATCH Watch whether machine learning connects more strongly with the city's health research strengths.
Research outlook for Minneapolis

What the papers — written in the city and about it — point to, split by the Prism stance layer: work that reads promising versus work that flags problems or urges caution.

Opportunities the research points to
Children's Health · 95Women's Health · 88Machine Learning · 76Healthcare · 72Mental Health · 62Neuroscience · 59Breast Cancer · 56Men's Health · 45Climate Change · 43Genetics · 38COVID-19 · 38Research · 37
Concerns the research raises
Children's Health · 112Healthcare · 105Women's Health · 86COVID-19 · 60Education · 51Research · 47Climate Change · 46Mental Health · 40Patients' Health · 37Public Health · 36Artificial Intelligence · 30Patient Care · 18

counts = papers carrying the theme · concerns merge cautionary, critical and problem-identifying work

Institutions
Orientation
Output by year (sample)
2026: 33020172026330
Opportunities (promising + breakthrough)
Children's Health · 95Women's Health · 88Machine Learning · 76Healthcare · 72Mental Health · 62Neuroscience · 59Breast Cancer · 56Men's Health · 45Climate Change · 43Genetics · 38COVID-19 · 38Research · 37
Cautions (cautionary + critical)
Children's Health · 45Women's Health · 34Healthcare · 30Climate Change · 18Patients' Health · 18COVID-19 · 16Research · 16Education · 16Health · 12Breast Cancer · 11Artificial Intelligence · 11Biodiversity · 11
Problems flagged
Healthcare · 75Children's Health · 67Women's Health · 52COVID-19 · 44Mental Health · 40Public Health · 36Education · 35Research · 31Climate Change · 28Patients' Health · 19Artificial Intelligence · 19Patient Care · 18
Top research topics
Functional Brain Connectivity Studies · 148Immune Cell Function and Interaction · 139Genomics and Phylogenetic Studies · 117Ecology and Vegetation Dynamics Studies · 115CAR-T cell therapy research · 113Neural dynamics and brain function · 113Plant and animal studies · 107Gut microbiota and health · 97Health Systems, Economic Evaluations, Quality of Life · 93Obesity, Physical Activity, Diet · 93Geology and Paleoclimatology Research · 91Child and Adolescent Psychosocial and Emotional Development · 91
Most-cited work
PaperYearCitedOrientation
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma20183936Promising
Cell entry mechanisms of SARS-CoV-220203418Breakthrough
Natural climate solutions20173203Problem Identifying
PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews20212628Descriptive
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction20222473Promising
Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter20182352Critical
Nonalcoholic Steatohepatitis20201349Problem Identifying
Anthropogenic contamination of tap water, beer, and sea salt20181194Descriptive
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML20191191Promising
Management of COVID-19 Respiratory Distress20201172Descriptive
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting20201154Descriptive
OpenMolcas: From Source Code to Insight20191102Descriptive
6th International Consultation on Incontinence. Recommendations of the International Scientific Committee…20181096Descriptive
Nanomaterials for cancer therapy: current progress and perspectives20211086Problem Identifying
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes20191055Descriptive

figures marked ≈ are scaled estimates from a partial sample · Prism stance layer over 2017+ papers

Need to go deeper than a city?

Fliar Prism answers any market, company or research question with the same depth — real-time, across every industry.

Explore Fliar Prism →